CB

Christopher Barys

North America, Florida, United States, Naples

Description

Christopher Barys is the US President and Chief Commercial Officer of Radiaction Medical. He previously worked at On Target Laboratories as ...

Investor Profile

Christopher Barys has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in Israel.
  • Strong thematic focus on Clinical Trials, Health Care, Medical.

Stage Focus

  • Series C (100%)

Country Focus

  • Israel (100%)

Industry Focus

  • Clinical Trials
  • Health Care
  • Medical
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Christopher Barys frequently co-invest with?

InnovaHealth Partners
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Christopher Barys?

Radiaction Medical

Tel Aviv, Tel Aviv, Israel

Radiaction blocks radiation at the source, providing comprehensive, head-to-toe radiation protection to the entire interventional team.

Clinical TrialsHealth CareMedicalMedical Device
Series CAug 29, 2023
Amount Raised: $12,600,000